Economic evaluation of early monotherapy with interferon versus delayed combination therapy with interferon and ribavirin in patients with acute hepatitis C

被引：0
|
作者：
Dintsios, C. M.
Haverkamp, A.
Krauth, C.
机构：
[1] Inst Qual & Efficiency Hlth Care, Cologne, Germany
[2] Hannover Med Sch, D-3000 Hannover, Germany
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63515-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [1] Economic evaluation of early monotherapy versus delayed combination therapy in patients with acute hepatitis C
    Dintsios, C. -M.
    Haverkamp, A.
    Wiegand, J.
    Gerlach, T.
    Gruener, N.
    Wedemeyer, H.
    Pape, G. R.
    Manns, M. P.
    Krauth, C.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S219 - S219
  • [2] Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany
    Dintsios, Charalabos-Markos
    Haverkamp, Alexander
    Wiegand, Johannes
    Gerlach, Tilman
    Wedemeyer, Heiner
    Pape, Gerd
    Manns, Michael Peter
    Krauth, Christian
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (03) : 278 - 288
  • [3] Firstline treatment for hepatitis C: combination interferon/ribavirin versus interferon monotherapy
    Lai, MY
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 : E130 - E133
  • [4] The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
    Hiramatsu, N
    Kasahara, A
    Nakanishi, F
    Toyama, T
    Tsujii, M
    Tsuji, S
    Kanto, T
    Takehara, T
    Kato, M
    Yoshihara, H
    Naito, M
    Katayama, K
    Hijioka, T
    Hagiwara, H
    Kubota, S
    Oshita, M
    Meren, H
    Masuzawa, M
    Haruna, Y
    Mita, E
    Suzuki, K
    Hayashi, N
    HEPATOLOGY RESEARCH, 2004, 29 (03) : 142 - 147
  • [5] Long term interferon and ribavirin combination therapy in chronic hepatitis C patients unresponsive to interferon monotherapy.
    Anderson, FH
    Rock, NR
    Sherlock, C
    HEPATOLOGY, 1998, 28 (04) : 716A - 716A
  • [6] Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT
    Brouwer, JT
    Hansen, BE
    Niesters, HGM
    Schalm, SW
    JOURNAL OF HEPATOLOGY, 1999, 30 (02) : 192 - 198
  • [7] Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Chiodo, F
    Magliano, E
    Furione, L
    Idéo, G
    JOURNAL OF HEPATOLOGY, 2000, 33 (03) : 463 - 468
  • [8] Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-α combination therapy and interferon-α monotherapy of patients with chronic hepatitis C
    Hoffmann, RM
    Berg, T
    Teuber, G
    Prümmer, O
    Leifeld, L
    Jung, MC
    Spengler, U
    Zeuzem, S
    Hopf, U
    Pape, GR
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1999, 37 (08): : 715 - 723
  • [9] Treatment of chronic hepatitis C in patients who failed interferon monotherapy: Effects of higher doses of interferon and ribavirin combination therapy
    Shiffman, ML
    Hofmann, CM
    Gabbay, J
    Luketic, VA
    Sterling, RK
    Sanyal, AJ
    Contos, MJ
    Ryan, MJ
    Yoshida, C
    Rustgi, V
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10): : 2928 - 2935
  • [10] Economic evaluation of chronic hepatitis C treatment by interferon-ribavirin combination therapy in Belgium
    Delwaide, J
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (04) : 233 - 236
12345